DWTX (STOCKS)
Dogwood Therapeutics, Inc. Common Stock
$1.880000
-0.110000 (-5.53%)
Prev close: $1.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gregory Duncan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $62.46M
- Employees
- 12
- P/E (TTM)
- -0.10
- P/B (TTM)
- 0.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $27.97M |
| Research and Development | $21.87M |
| Other Operating Expenses | $6.10M |
| Operating Income/Loss | -$27.97M |
| Income/Loss From Continuing Operations After Tax | -$34.26M |
| Income/Loss From Continuing Operations Before Tax | -$34.04M |
| Income Tax Expense/Benefit | $221.10K |
| Income Tax Expense/Benefit, Deferred | $221.10K |
| Net Income/Loss | -$34.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.26M |
| Preferred Stock Dividends And Other Adjustments | $1.26M |
| Basic Earnings Per Share | -$7.13 |
| Diluted Earnings Per Share | -$7.13 |
| Basic Average Shares | 4,977,446 |
| Diluted Average Shares | 4,977,446 |
| Assets | $90.17M |
| Current Assets | $8.43M |
| Noncurrent Assets | $81.74M |
| Fixed Assets | $12.75K |
| Intangible Assets | $68.99M |
| Non-current Prepaid Expenses | $19.04K |
| Other Non-current Assets | $12.72M |
| Liabilities | $15.27M |
| Current Liabilities | $3.06M |
| Accounts Payable | $760.95K |
| Wages | $745.08K |
| Other Current Liabilities | $1.55M |
| Noncurrent Liabilities | $12.22M |
| Equity | $74.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $74.90M |
| Liabilities And Equity | $90.17M |
| Net Cash Flow From Operating Activities | -$15.62M |
| Net Cash Flow From Operating Activities, Continuing | -$15.62M |
| Net Cash Flow From Investing Activities | $8.33M |
| Net Cash Flow From Investing Activities, Continuing | $8.33M |
| Net Cash Flow From Financing Activities | $7.28M |
| Net Cash Flow From Financing Activities, Continuing | $7.28M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$30.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.98M |
| Other Comprehensive Income/Loss | $3.28M |